---
document_datetime: 2025-12-02 07:02:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/lymphoseek.html
document_name: lymphoseek.html
version: success
processing_time: 0.104396
conversion_datetime: 2025-12-29 21:07:23.796921
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Lymphoseek

[RSS](/en/individual-human-medicine.xml/66900)

##### Withdrawn

This medicine's authorisation has been withdrawn

tilmanocept Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Lymphoseek](#news-on)
- [More information on Lymphoseek](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 10 June 2024, the European Commission withdrew the marketing authorisation for Lymphoseek (tilmanocept) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Navidea Biopharmaceuticals Europe Ltd., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Lymphoseek was granted marketing authorisation in the EU on 19 November 2014 for use in the delineation and localisation of lymph nodes. The marketing authorisation was initially valid for a 5-year period. It was granted unlimited validity in 2019.

The European Public Assessment Report (EPAR) for Lymphoseek is updated to indicate that the marketing authorisation is no longer valid.

Lymphoseek : EPAR - Summary for the public

Reference Number: EMA/601221/2014

English (EN) (631.84 KB - PDF)

**First published:** 08/01/2015

**Last updated:** 14/08/2024

[View](/en/documents/overview/lymphoseek-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-617)

български (BG) (727.49 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/bg/documents/overview/lymphoseek-epar-summary-public_bg.pdf)

español (ES) (631.72 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/es/documents/overview/lymphoseek-epar-summary-public_es.pdf)

čeština (CS) (676.08 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/cs/documents/overview/lymphoseek-epar-summary-public_cs.pdf)

dansk (DA) (631.78 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/da/documents/overview/lymphoseek-epar-summary-public_da.pdf)

Deutsch (DE) (632.42 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/de/documents/overview/lymphoseek-epar-summary-public_de.pdf)

eesti keel (ET) (659.06 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/et/documents/overview/lymphoseek-epar-summary-public_et.pdf)

ελληνικά (EL) (686.68 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/el/documents/overview/lymphoseek-epar-summary-public_el.pdf)

français (FR) (632.83 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fr/documents/overview/lymphoseek-epar-summary-public_fr.pdf)

hrvatski (HR) (651.51 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hr/documents/overview/lymphoseek-epar-summary-public_hr.pdf)

italiano (IT) (630.75 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/it/documents/overview/lymphoseek-epar-summary-public_it.pdf)

latviešu valoda (LV) (671.34 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lv/documents/overview/lymphoseek-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (656.06 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lt/documents/overview/lymphoseek-epar-summary-public_lt.pdf)

magyar (HU) (669.66 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hu/documents/overview/lymphoseek-epar-summary-public_hu.pdf)

Malti (MT) (675.2 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/mt/documents/overview/lymphoseek-epar-summary-public_mt.pdf)

Nederlands (NL) (631.2 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/nl/documents/overview/lymphoseek-epar-summary-public_nl.pdf)

polski (PL) (675.51 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pl/documents/overview/lymphoseek-epar-summary-public_pl.pdf)

português (PT) (631.91 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pt/documents/overview/lymphoseek-epar-summary-public_pt.pdf)

română (RO) (653.74 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/ro/documents/overview/lymphoseek-epar-summary-public_ro.pdf)

slovenčina (SK) (673.47 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sk/documents/overview/lymphoseek-epar-summary-public_sk.pdf)

slovenščina (SL) (667.76 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sl/documents/overview/lymphoseek-epar-summary-public_sl.pdf)

Suomi (FI) (630.55 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fi/documents/overview/lymphoseek-epar-summary-public_fi.pdf)

svenska (SV) (631.16 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sv/documents/overview/lymphoseek-epar-summary-public_sv.pdf)

Lymphoseek : EPAR - Risk-management-plan summary

English (EN) (695.86 KB - PDF)

**First published:** 08/01/2015

**Last updated:** 14/08/2024

[View](/en/documents/rmp-summary/lymphoseek-epar-risk-management-plan-summary_en.pdf)

## Product information

Lymphoseek : EPAR - Product Information

English (EN) (995.42 KB - PDF)

**First published:** 08/01/2015

**Last updated:** 14/08/2024

[View](/en/documents/product-information/lymphoseek-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-96)

български (BG) (1.88 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/bg/documents/product-information/lymphoseek-epar-product-information_bg.pdf)

español (ES) (977.53 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/es/documents/product-information/lymphoseek-epar-product-information_es.pdf)

čeština (CS) (1.06 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/cs/documents/product-information/lymphoseek-epar-product-information_cs.pdf)

dansk (DA) (1001.36 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/da/documents/product-information/lymphoseek-epar-product-information_da.pdf)

Deutsch (DE) (960.21 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/de/documents/product-information/lymphoseek-epar-product-information_de.pdf)

eesti keel (ET) (1.24 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/et/documents/product-information/lymphoseek-epar-product-information_et.pdf)

ελληνικά (EL) (1.08 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/el/documents/product-information/lymphoseek-epar-product-information_el.pdf)

français (FR) (969.97 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fr/documents/product-information/lymphoseek-epar-product-information_fr.pdf)

hrvatski (HR) (1.03 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hr/documents/product-information/lymphoseek-epar-product-information_hr.pdf)

íslenska (IS) (975.29 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/is/documents/product-information/lymphoseek-epar-product-information_is.pdf)

italiano (IT) (967.07 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/it/documents/product-information/lymphoseek-epar-product-information_it.pdf)

latviešu valoda (LV) (1.01 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lv/documents/product-information/lymphoseek-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1018.05 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lt/documents/product-information/lymphoseek-epar-product-information_lt.pdf)

magyar (HU) (1.1 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hu/documents/product-information/lymphoseek-epar-product-information_hu.pdf)

Malti (MT) (1.12 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/mt/documents/product-information/lymphoseek-epar-product-information_mt.pdf)

Nederlands (NL) (964.11 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/nl/documents/product-information/lymphoseek-epar-product-information_nl.pdf)

norsk (NO) (968.13 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/no/documents/product-information/lymphoseek-epar-product-information_no.pdf)

polski (PL) (1.08 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pl/documents/product-information/lymphoseek-epar-product-information_pl.pdf)

português (PT) (935.82 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pt/documents/product-information/lymphoseek-epar-product-information_pt.pdf)

română (RO) (1.04 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/ro/documents/product-information/lymphoseek-epar-product-information_ro.pdf)

slovenčina (SK) (1.04 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sk/documents/product-information/lymphoseek-epar-product-information_sk.pdf)

slovenščina (SL) (1.08 MB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sl/documents/product-information/lymphoseek-epar-product-information_sl.pdf)

Suomi (FI) (960.37 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fi/documents/product-information/lymphoseek-epar-product-information_fi.pdf)

svenska (SV) (991.81 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sv/documents/product-information/lymphoseek-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0023/G 10/06/2024

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Lymphoseek : EPAR - All Authorised presentations

English (EN) (640.1 KB - PDF)

**First published:** 08/01/2015

**Last updated:** 14/08/2024

[View](/en/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-143)

български (BG) (700.74 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/bg/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_bg.pdf)

español (ES) (638 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/es/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_es.pdf)

čeština (CS) (671.48 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/cs/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (639.55 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/da/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (644.2 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/de/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (649.87 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/et/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (668.78 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/el/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_el.pdf)

français (FR) (638.14 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fr/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (680.84 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hr/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (640.38 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/is/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_is.pdf)

italiano (IT) (638.23 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/it/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (716.89 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lv/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (681.22 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/lt/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (676.61 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/hu/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (699.1 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/mt/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (640.73 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/nl/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (637.38 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/no/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_no.pdf)

polski (PL) (702.87 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pl/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_pl.pdf)

português (PT) (658.9 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/pt/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_pt.pdf)

română (RO) (655.16 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/ro/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (676.4 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sk/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (673.2 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sl/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (633.57 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/fi/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (640.77 KB - PDF)

**First published:**

08/01/2015

**Last updated:**

14/08/2024

[View](/sv/documents/all-authorised-presentations/lymphoseek-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Lymphoseek Active substance tilmanocept International non-proprietary name (INN) or common name tilmanocept Therapeutic area (MeSH) Radionuclide Imaging Anatomical therapeutic chemical (ATC) code V09IA09

### Pharmacotherapeutic group

- Tumour detection
- Diagnostic radiopharmaceuticals

### Therapeutic indication

This medicinal product is for diagnostic use only.

Radiolabelled Lymphoseek is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity.

External imaging and intraoperative evaluation may be performed using a gamma detection device.

## Authorisation details

EMA product number EMEA/H/C/002085 Marketing authorisation holder

Navidea Biopharmaceuticals Europe Ltd.

Kilminion South

Opinion adopted 25/09/2014 Marketing authorisation issued 19/11/2014 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Lymphoseek : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (705.19 KB - PDF)

**First published:** 19/10/2016

**Last updated:** 14/08/2024

[View](/en/documents/procedural-steps-after/lymphoseek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Lymphoseek : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/264502/2014

English (EN) (3.29 MB - PDF)

**First published:** 08/01/2015

**Last updated:** 14/08/2024

[View](/en/documents/assessment-report/lymphoseek-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Lymphoseek

Adopted

Reference Number: EMA/CHMP/525445/2014

English (EN) (625.22 KB - PDF)

**First published:** 26/09/2014

**Last updated:** 14/08/2024

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-lymphoseek_en.pdf)

#### News on Lymphoseek

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-september-2014) 26/09/2014

#### More information on Lymphoseek

- [Lymphoseek - direct healthcare professional communication (DHPC)](/en/medicines/dhpc/lymphoseek)
- [Lymphoseek - direct healthcare professional communication (DHPC)](/en/medicines/dhpc/lymphoseek-0)
- [Lymphoseek - direct healthcare professional communication (DHPC)](/en/medicines/dhpc/lymphoseek-1)

**This page was last updated on** 14/08/2024

## Share this page

[Back to top](#main-content)